Chong Kun Dang Pharmaceutical종근당
185750 · KOSPI · ₩185750 · 종근당
₩61,900▲ ₩600 (0.98%)End-of-day · Oct 28, 2026 · End-of-day prices.
Filings
- Amended: Half-year report (Jun 2026)[기재정정]반기보고서 (2026.06)Oct 22, 2026Open on DART
Predicted impact: Low
- Amended: Half-year report (Jun 2026)[기재정정]반기보고서 (2026.06)Oct 22, 2026Open on DART
Predicted impact: Low
- Amended: Half-year report (Jun 2026)[기재정정]반기보고서 (2026.06)Oct 22, 2026Open on DART
Predicted impact: Low
- Change in largest shareholder's holdings최대주주등소유주식변동신고서Oct 8, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Oct 8, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Oct 8, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Oct 8, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Oct 8, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Sep 30, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Aug 31, 2026Open on DART
- Trading Plan Report for Executives and Major Shareholders' Specific Securities임원ㆍ주요주주특정증권등거래계획보고서Aug 28, 2026Open on DART
- Trading Plan Report for Executives and Major Shareholders' Specific Securities임원ㆍ주요주주특정증권등거래계획보고서Aug 28, 2026Open on DART
- Half-year report (Jun 2026)반기보고서 (2026.06)Aug 14, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(약식)Aug 13, 2026Open on DART
- Preliminary earnings영업(잠정)실적(공정공시)Jul 31, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항 (고혈압 치료제로 개발중인 CKD339의 식약처(MFDS) 제3상 임상시험 계획 승인)Jul 27, 2026Open on DART
- Fair Trade Self-Compliance Program Operation Status (Informational Disclosure)공정거래자율준수프로그램운영현황(안내공시)Jul 22, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Jul 16, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(약식)Jul 1, 2026Open on DART
- Disclosure Related to Sustainability Management Report, etc. (Voluntary Disclosure)지속가능경영보고서등관련사항(자율공시)Jun 30, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(약식)Jun 26, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Jun 24, 2026Open on DART
- New Facility Investment, etc.신규시설투자등Jun 11, 2026Open on DART
- Response to rumour or news report풍문또는보도에대한해명(미확정)Jun 10, 2026Open on DART
- Disclosure of Corporate Governance Report기업지배구조보고서공시Jun 1, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(약식)Jun 1, 2026Open on DART
- Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항 (고혈압 치료제로 개발중인 CKD339의 식약처(MFDS) 제3상 임상시험 계획 승인 신청)May 14, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Apr 30, 2026Open on DART
- Preliminary earnings영업(잠정)실적(공정공시)Apr 29, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Apr 21, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Apr 7, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Apr 2, 2026Open on DART
- Annual general meeting results정기주주총회결과Mar 26, 2026Open on DART
- Change in largest shareholder's holdings최대주주등소유주식변동신고서Mar 23, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 23, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Mar 23, 2026Open on DART
- Annual report (Dec 2025)사업보고서 (2025.12)Mar 18, 2026Open on DART
- Audit report submitted감사보고서제출Mar 16, 2026Open on DART
- Change in largest shareholder's holdings최대주주등소유주식변동신고서Mar 13, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 13, 2026Open on DART
- Cash dividend decision현금ㆍ현물배당결정Mar 11, 2026Open on DART
- Shareholders' meeting called주주총회소집결의Mar 11, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항 (듀비엠폴서방정(CKD383) 식품의약품안전처 국내 품목허가 승인)Mar 11, 2026Open on DART
- Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Mar 11, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Mar 11, 2026Open on DART
- Change in largest shareholder's holdings최대주주등소유주식변동신고서Mar 5, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 5, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Mar 5, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Feb 3, 2026Open on DART
Titles in Korean until English translations are added.
Also known as: Chong Kun Dang Pharmaceutical / 종근당 / 185750 / KRX:185750
Source: KRX statistical information